Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives $32.43 Consensus PT from Brokerages
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has received an average rating of “Moderate Buy” from the nine analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the […]
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has received an average rating of “Moderate Buy” from the nine analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the […]
